Literature DB >> 9551909

Aberrant intermolecular disulfide bonding in a mutant HLA-DM molecule: implications for assembly, maturation, and function.

R Busch1, R C Doebele, E von Scheven, J Fahrni, E D Mellins.   

Abstract

HLA-DM (abbreviated DM) is an MHC-encoded glycoprotein that catalyzes the selective release of peptides, including class II-associated invariant chain peptides, from MHC class II molecules. To perform its function, DM must assemble in the endoplasmic reticulum (ER), travel to endosomes, and interact productively with class II molecules. We have described previously an EBV-transformed B cell line, 7.12.6, which displays a partial Ag presentation defect and expresses a mutated DM beta-chain with Cys79 replaced by Tyr. In this study, we show that HLA-DR molecules in 7.12.6 have a defect in peptide loading and accumulate class II-associated invariant chain peptides (CLIP). Peptide loading is restored by transfection of wild-type DMB. The mutant DM molecules exit the ER slowly and are degraded rapidly, resulting in greatly reduced levels of mutant DM in post-Golgi compartments. Whereas wild-type DM forms noncovalent alphabeta dimers, such dimers form inefficiently in 7.12.6; many mutant DM beta-chains instead form a disulfide-bonded dimer with DM alpha. Homodimers of DM beta are also detected in 7.12.6 and in the alpha-chain defective mutant, 2.2.93. We conclude that during folding of wild-type DM, the native conformation is stabilized by a conserved disulfide bond involving Cys79beta and by noncovalent contacts with DM alpha. Without these interactions, DM beta can form malfolded structures containing interchain disulfide bonds; malfolding is correlated with ER retention and accelerated degradation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9551909

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  The Dendritic Cell Major Histocompatibility Complex II (MHC II) Peptidome Derives from a Variety of Processing Pathways and Includes Peptides with a Broad Spectrum of HLA-DM Sensitivity.

Authors:  Cristina C Clement; Aniuska Becerra; Liusong Yin; Valerio Zolla; Liling Huang; Simone Merlin; Antonia Follenzi; Scott A Shaffer; Lawrence J Stern; Laura Santambrogio
Journal:  J Biol Chem       Date:  2016-01-06       Impact factor: 5.157

2.  Susceptibility to HLA-DM protein is determined by a dynamic conformation of major histocompatibility complex class II molecule bound with peptide.

Authors:  Liusong Yin; Peter Trenh; Abigail Guce; Marek Wieczorek; Sascha Lange; Jana Sticht; Wei Jiang; Marissa Bylsma; Elizabeth D Mellins; Christian Freund; Lawrence J Stern
Journal:  J Biol Chem       Date:  2014-07-07       Impact factor: 5.157

3.  Evaluating the Role of HLA-DM in MHC Class II-Peptide Association Reactions.

Authors:  Liusong Yin; Zachary J Maben; Aniuska Becerra; Lawrence J Stern
Journal:  J Immunol       Date:  2015-06-10       Impact factor: 5.422

4.  Broadly recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles.

Authors:  Aniuska Becerra-Artiles; J Mauricio Calvo-Calle; Mary Dawn Co; Padma P Nanaware; John Cruz; Grant C Weaver; Liying Lu; Catherine Forconi; Robert W Finberg; Ann M Moormann; Lawrence J Stern
Journal:  Cell Rep       Date:  2022-05-27       Impact factor: 9.995

5.  A novel method to measure HLA-DM-susceptibility of peptides bound to MHC class II molecules based on peptide binding competition assay and differential IC(50) determination.

Authors:  Liusong Yin; Lawrence J Stern
Journal:  J Immunol Methods       Date:  2014-02-25       Impact factor: 2.303

6.  Measurement of protein synthesis using heavy water labeling and peptide mass spectrometry: Discrimination between major histocompatibility complex allotypes.

Authors:  Alessandra De Riva; Michael J Deery; Sarah McDonald; Torben Lund; Robert Busch
Journal:  Anal Biochem       Date:  2010-04-18       Impact factor: 3.365

7.  Functional HLA-DM on the surface of B cells and immature dendritic cells.

Authors:  S O Arndt; A B Vogt; S Markovic-Plese; R Martin; G Moldenhauer; A Wölpl; Y Sun; D Schadendorf; G J Hämmerling; H Kropshofer
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

8.  Pulse-chase analysis for studies of MHC class II biosynthesis, maturation, and peptide loading.

Authors:  Tieying Hou; Cornelia H Rinderknecht; Andreas V Hadjinicolaou; Robert Busch; Elizabeth Mellins
Journal:  Methods Mol Biol       Date:  2013

9.  Pleiotropic consequences of metabolic stress for the major histocompatibility complex class II molecule antigen processing and presentation machinery.

Authors:  Cristina C Clement; Padma P Nanaware; Takahiro Yamazaki; Maria Pia Negroni; Karthik Ramesh; Kateryna Morozova; Sangeetha Thangaswamy; Austin Graves; Hei Jung Kim; Tsai Wanxia Li; Marco Vigano'; Rajesh K Soni; Massimo Gadina; Harley Y Tse; Lorenzo Galluzzi; Paul A Roche; Lisa K Denzin; Lawrence J Stern; Laura Santambrogio
Journal:  Immunity       Date:  2021-03-15       Impact factor: 31.745

10.  HLA-DO acts as a substrate mimic to inhibit HLA-DM by a competitive mechanism.

Authors:  Abigail I Guce; Sarah E Mortimer; Taejin Yoon; Corrie A Painter; Wei Jiang; Elizabeth D Mellins; Lawrence J Stern
Journal:  Nat Struct Mol Biol       Date:  2012-12-09       Impact factor: 15.369

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.